Oncology Drugs Market Research Report, Growth & Forecast

The Japan Locally Advanced Pancreatic Cancer Market was valued at US$ 47.09 million in 2024 and is anticipated to reach US$ 89.04 million by 2033, at a CAGR of 0.074 from 2026 to 2032. The report deli...

The Aromatase Inhibitor Drug Class Market was valued at US$ 4.1 Billion in 2024 and is anticipated to reach US$ 6.7 Billion by 2033, at a CAGR of 0.055 from 2026 to 2032. The report delivers in-depth...

According to our (Global Info Research) latest study, the global Trabectedin for Chemotherapy market size was valued at US$ 309 million in 2025 and is forecast to a readjusted size of US$ 533 million...

The global Trabectedin for Chemotherapy market size is expected to reach $ 533 million by 2032, rising at a market growth of 9.0% CAGR during the forecast period (2026-2032). In 2025, global productio...

The Radioligand Therapy Market was valued at US$ 2.41 billion in 2024 and is anticipated to reach US$ 15.80 billion by 2033, at a CAGR of 0.219 from 2026 to 2032. The report delivers in-depth insights...

The Epithelial Ovarian Cancer Drugs Market was valued at in and is anticipated to reach by 2031, at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, inc...

The global market for radioligand therapeutics in cancer treatment is estimated to grow from $2.6 billion in 2025 to $4.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% f...

HNY Research projects that the Oncolytic Virus Therapy market size will grow from 107.59 Million USD in 2025 to 216.41 Million USD by 2031, at an estimated CAGR of 12.35%. The base year considered for...

HNY Research projects that the Methotrexate market size will grow from 552.63 Million USD in 2025 to 666.14 Million USD by 2031, at an estimated CAGR of 3.16%. The base year considered for the study i...

HNY Research projects that the Vinblastinesulphate market size will grow from 22.95 Million USD in 2025 to 27.72 Million USD by 2031, at an estimated CAGR of 3.2%. The base year considered for the stu...

The Neuroendocrine Cancer Market was valued at in and is anticipated to reach by 2031, at a CAGR of 0.106 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including r...

The Skin Cancer Drugs Market was valued at in and is anticipated to reach by , at a CAGR of 0.102 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...

HNY Research projects that the Paclitaxel market size will grow from 140.48 Million USD in 2025 to 241.03 Million USD by 2031, at an estimated CAGR of 9.41%. The base year considered for the study is...

According to our (Global Info Research) latest study, the global AR PROTAC Drugs for Cancer market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ 765 million by 203...

According to our (Global Info Research) latest study, the global AR Targeted PROTAC Drugs market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ 618 million by 2032...

The global AR PROTAC Drugs for Cancer market size is expected to reach $ 765 million by 2032, rising at a market growth of 24.7% CAGR during the forecast period (2026-2032). No AR PROTAC Drugs for Can...

The global AR Targeted PROTAC Drugs market size is expected to reach $ 618 million by 2032, rising at a market growth of 20.8% CAGR during the forecast period (2026-2032). No AR Targeted PROTAC Drugs...

The Head and Neck Squamous Cell Carcinoma Market was valued at US$ 2.2 billion in 2022 and is anticipated to reach US$ 4.3 billion by 2030, at a CAGR of 0.088 from 2026 to 2032. The report delivers in...

HNY Research projects that the Checkpoint Inhibitors for Treating Cancer market size will grow from 19895.32 Million USD in 2025 to 96272.75 Million USD by 2031, at an estimated CAGR of 30.05%. The ba...

HNY Research projects that the Platinum based Cancer Drug market size will grow from 1643.89 Million USD in 2025 to 1993.08 Million USD by 2031, at an estimated CAGR of 3.26%. The base year considered...

The global Automatic Radiation Dose Fractionation Robot market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United...

HNY Research projects that the Mitomycin C market size will grow from 102.72 Million USD in 2025 to 136.09 Million USD by 2031, at an estimated CAGR of 4.8%. The base year considered for the study is...

HNY Research projects that the Paclitaxel Injection market size will grow from 4215.87 Million USD in 2025 to 8789.89 Million USD by 2031, at an estimated CAGR of 13.03%. The base year considered for...

Findings & Highlights: Global & Regional Market Opportunity AnalysisClinical Trials Insight On Key Therapies In Trials: > 15 TherapiesFerroptosis Targeting Therapies Clinical Trials Insight By Compan...

The global HER2 ADC Drugs for Cancer market size is predicted to grow from US$ 7625 million in 2025 to US$ 13720 million in 2032; it is expected to grow at a CAGR of 8.5% from 2026 to 2032. In 2025, g...

The global HER2 Targeting ADC Drugs market size is predicted to grow from US$ 7811 million in 2025 to US$ 14054 million in 2032; it is expected to grow at a CAGR of 8.5% from 2026 to 2032. In 2025, gl...

The global Nectin-4 ADC Drugs market size is predicted to grow from US$ 1767 million in 2025 to US$ 3240 million in 2032; it is expected to grow at a CAGR of 8.9% from 2026 to 2032. In 2025, global Ne...

The global Nectin-4 ADC Innovative Drugs market size is predicted to grow from US$ 1661 million in 2025 to US$ 3036 million in 2032; it is expected to grow at a CAGR of 8.8% from 2026 to 2032. In 2025...

The global Nectin-4-Directed Antibody Drug Conjugates (ADC) market size is predicted to grow from US$ 1746 million in 2025 to US$ 3330 million in 2032; it is expected to grow at a CAGR of 9.6% from 20...

The global Oncology Nuclear Medicine Equipment market size is predicted to grow from US$ 1886 million in 2025 to US$ 3094 million in 2032; it is expected to grow at a CAGR of 6.8% from 2026 to 2032. I...

The global Radioligand Therapy Drugs for Cancer market size is predicted to grow from US$ 3203 million in 2025 to US$ 5447 million in 2032; it is expected to grow at a CAGR of 8.0% from 2026 to 2032....

The global Radioligand Therapy Drugs market size is predicted to grow from US$ 3087 million in 2025 to US$ 5316 million in 2032; it is expected to grow at a CAGR of 8.3% from 2026 to 2032. In 2025, gl...

The global Radiosurgery Planning System market size is predicted to grow from US$ 1258 million in 2025 to US$ 1997 million in 2032; it is expected to grow at a CAGR of 7.5% from 2026 to 2032. Radiosur...

The global Targeted Therapy Drugs for Cancer market size is predicted to grow from US$ 118360 million in 2025 to US$ 191441 million in 2032; it is expected to grow at a CAGR of 7.6% from 2026 to 2032....

According to our (Global Info Research) latest study, the global Immunotherapy Products market size was valued at US$ 271951 million in 2025 and is forecast to a readjusted size of US$ 404701 million...

The global Immunotherapy Products market size is expected to reach $ 404701 million by 2032, rising at a market growth of 5.8% CAGR during the forecast period (2026-2032). Immunotherapy products refer...

The Europe Ovarian Cancer Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regiona...

The Hurthle Cell Carcinoma Market was valued at in and is anticipated to reach by , at a CAGR of 0.06 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regio...

The global Ubenimex Capsules market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Ubenimex (also known as bestatin)...

The global High-Frequency Hyperthermia Device market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. High-Frequency H...

The global Aromatase Inhibitors?AI? market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Aromatase inhibitors are a...

The global Nonsteroidal Aromatase Inhibitors market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Nonsteroidal arom...

The global Tamoxifen Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Tamoxifen is a selective estrogen r...

According to Stratistics MRC, the Global Cancer Immunotherapy Market is accounted for $140.63 billion in 2025 and is expected to reach $250.55 billion by 2032 growing at a CAGR of 8.6% during the fore...

According to Stratistics MRC, the Global Personalized Oncology Market is accounted for $118.38 billion in 2025 and is expected to reach $227.78 billion by 2032 growing at a CAGR of 9.8% during the for...

The Angiosarcoma Treatment Market was valued at USD 253.1 million in 2022 and is anticipated to reach USD 412.3 million by 2030, at a CAGR of 0.064 from 2026 to 2032. The report delivers in-depth insi...

The Germ Cell Tumor Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including reg...

The Lung Cancer Therapeutics Market was valued at US$ 24.00 Billion in 2023 and is anticipated to reach US$ 55.09 Billion by 2033, at a CAGR of 0.088 from 2026 to 2032. The report delivers in-depth in...

The Metastatic Colorectal Cancer Market was valued at US$ 3.4 billion in 2022 and is anticipated to reach US$ 4.8 billion by 2030, at a CAGR of 0.046 from 2026 to 2032. The report delivers in-depth in...

According to our (Global Info Research) latest study, the global BNCT (Boron Neutron Capture Therapy) Injectable Drug market size was valued at US$ 65.85 million in 2025 and is forecast to a readjuste...